Adrenaline during heart artery procedure to prevent poor blood flow
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether giving adrenaline (a medicine that helps blood vessels relax) directly into the heart artery during a procedure to open a blocked artery can prevent a complication called 'no reflow' (where blood still doesn't flow well after the blockage is cleared). It is for people having a specific type of heart attack (STEMI) and being treated within 12 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are having a STEMI heart attack (a specific type seen on an ECG) and are being treated within 12 hours of symptoms starting.
- You are not pregnant.
- You do not have certain heart conditions, like a blocked artery that can't be opened (CTO), a tear in the artery wall (SCAD), or a very weak heart (cardiomyopathy).
- You are not in cardiogenic shock (heart too weak to pump blood).
- You do not have uncontrolled high blood pressure (systolic over 180 or diastolic over 110), a serious heart rhythm problem, or an allergy to adrenaline.
- You are willing to give your consent for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a medication called adenosine before emergency heart catheterization (a tube procedure to open blocked arteries) helps patients having a heart attack. Adenosine may protect heart tissue and improve outcomes.
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
This study looks at whether giving medication before the heart procedure can reduce tiny blood-vessel blockages (and “no-flow” areas) after a certain type of heart attack. It may help improve heart blood flow right after treatment in people who meet specific procedure and timing criteria.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This study looks at whether “ischemic postconditioning” (briefly changing blood flow right after opening a blocked heart artery) can improve outcomes in people with a specific type of heart attack. It’s meant for patients who get primary PCI (a catheter-based procedure to reopen the artery) soon after symptoms start.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.